Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance.
Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chéry L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Gregg JR, et al. Among authors: pisters l. Biomark Res. 2024 Nov 9;12(1):134. doi: 10.1186/s40364-024-00678-7. Biomark Res. 2024. PMID: 39522029 Free PMC article.
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.
Davis JW, Ward JF 3rd, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Davis JW, et al. Among authors: pisters ll. BJU Int. 2016 Jul;118(1):68-76. doi: 10.1111/bju.13193. Epub 2015 Jul 4. BJU Int. 2016. PMID: 26059275 Free PMC article.
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort.
Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. Gregg JR, et al. Among authors: pisters l. Urology. 2020 Apr;138:91-97. doi: 10.1016/j.urology.2019.11.041. Epub 2019 Dec 30. Urology. 2020. PMID: 31899230 Free PMC article.
The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Chéry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. Gregg JR, et al. Among authors: pisters l. Urol Oncol. 2024 Apr;42(4):116.e1-116.e7. doi: 10.1016/j.urolonc.2023.12.013. Epub 2024 Jan 22. Urol Oncol. 2024. PMID: 38262868
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.
Hahn AW, Manyam GC, Chapin BF, Zhang M, Yu Y, Pettaway CA, Chery L, Pisters LL, Ward JF, Gregg JR, Papadopoulos J, Kamat AM, Lozano M, Hoang A, Broom B, Wang X, Huff CD, Logothetis CJ, Troncoso P, Pilié PG, Davis JW. Hahn AW, et al. Among authors: pisters ll. BJU Int. 2024 Sep;134(3):449-458. doi: 10.1111/bju.16414. Epub 2024 Jun 4. BJU Int. 2024. PMID: 38837608 Clinical Trial.
Salvage therapy for radiorecurrent prostate cancer.
Ward JF, Pagliaro LC, Pisters LL. Ward JF, et al. Among authors: pisters ll. Curr Probl Cancer. 2008 Nov-Dec;32(6):242-71. doi: 10.1016/j.currproblcancer.2008.10.001. Curr Probl Cancer. 2008. PMID: 19064119 Review. No abstract available.
262 results